Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.920
-0.120 (-5.88%)
At close: Apr 1, 2025, 4:00 PM
2.080
+0.160 (8.33%)
After-hours: Apr 1, 2025, 7:03 PM EDT

Aprea Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-12.96-14.29-112.66-37.13-53.48
Depreciation & Amortization
0.020.010.190.270.23
Asset Writedown & Restructuring Costs
--72.52--
Stock-Based Compensation
0.510.4416.987.814.98
Other Operating Activities
-0.070.04-0.28-0.320.89
Change in Accounts Payable
-0.310.83-0.86-2.732.33
Change in Unearned Revenue
-0.530.53---
Change in Other Net Operating Assets
-0.210.26-0.9-5.63.25
Operating Cash Flow
-13.56-12.18-25.01-37.69-41.8
Capital Expenditures
-0.02-0.09---0.03
Investing Cash Flow
-0.02-0.09---0.03
Issuance of Common Stock
16.145.790.681.750.15
Other Financing Activities
-1.32-0.65---
Financing Cash Flow
14.825.140.681.750.15
Foreign Exchange Rate Adjustments
-0.01-0.010.04-00.61
Net Cash Flow
1.24-7.14-24.29-35.94-41.07
Free Cash Flow
-13.57-12.27-25.01-37.69-41.83
Free Cash Flow Margin
-903.26%-2103.92%---
Free Cash Flow Per Share
-2.46-3.39-15.09-35.41-39.59
Levered Free Cash Flow
-9.29-7.67-7.97--
Unlevered Free Cash Flow
-9.29-7.67-7.97--
Change in Net Working Capital
0.84-1.641.78--
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q